Literature DB >> 10843472

Apoptosis and apoptosis-related proteins (Fas, Fas ligand, bcl-2, p53) in macrophages of human ovarian epithelial tumors.

H Ben-Hur1, P Gurevich, A Ben-Arie, M Huszar, V Berman, Y Tendler, R Tchanishev, G Mor, S Gershon, I Zusman.   

Abstract

Apoptosis and the apoptosis-related proteins (ARP) (Fas, Fas ligand (FasL), bcl-2 and p53) were analyzed in macrophages of different human ovarian epithelial tumors. Few macrophages were found in ovaries of women without oncologic disorders. In ovarian benign cysts, macrophagic density reached 4.9+/-1.2 per 50,000 microm2, most were present in lymphoid-macrophagic infiltrates of the sub-epithelial stroma (3.7+/-0.5% of the area of a slide), and 23.4% were Fas and FasL positive. In borderline tumors, the expanse of lymphoid infiltrates increased to 15.6% of the area of a slide, and the number of macrophages increased 2.4-fold compared to benign cysts. Of the macrophages, 83-88% expressed Fas and FasL, few had bcl-2 and CD25 receptors, and isolated ones were apoptotic. In carcinomas with high lymphoid-macrophagic infiltration, the infiltrate occupied 17.5% of the slide and macrophages amounted to 12.1+/-1.5/50,000 microm2. Many macrophages were in regions of grouping apoptosis of tumor epithelial cells and significantly fewer expressed Fas, FasL and bcl-2. Macrophages destroyed by apoptosis accounted for 4.6%. In carcinomas with low lymphoid-macrophageal infiltration, the area of the last was 5.1% of the slide. There were 8.6+/-0.8 macrophages/50,000 microm2, mainly at the margins of zones of necrosis and of tumor cells' grouping apoptosis. Extensive macrophagic infiltration into tumor parenchyma is one way by which the host immune system destroys tumors. Fas and FasL appear in macrophages of benign cysts, but in borderline tumors and in carcinomas with low infiltration their concentration increases sharply, to 79.8% and 96.6%, respectively. In 4.5% of these cells, apoptosis of macrophages was seen. The findings suggest that macrophages participate in the transfer of ARP to tumor epithelial cells, thereby inducing their apoptosis, but undergoing the simultaneous apoptosis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10843472

Source DB:  PubMed          Journal:  Eur J Gynaecol Oncol        ISSN: 0392-2936            Impact factor:   0.196


  6 in total

1.  Induction of apoptosis in glioma cells by molecules released from activated macrophages.

Authors:  George G Chen; Ying S Chu; Ernest C W Chak; Billy C S Leung; Wai S Poon
Journal:  J Neurooncol       Date:  2002-05       Impact factor: 4.130

2.  Serum biomarker panels for the discrimination of benign from malignant cases in patients with an adnexal mass.

Authors:  Brian Nolen; Liudmila Velikokhatnaya; Adele Marrangoni; Koen De Geest; Aleksey Lomakin; Robert C Bast; Anna Lokshin
Journal:  Gynecol Oncol       Date:  2010-03-24       Impact factor: 5.482

3.  Roles of Fas and Fas ligand during mammary gland remodeling.

Authors:  J Song; E Sapi; W Brown; J Nilsen; K Tartaro; B M Kacinski; J Craft; F Naftolin; G Mor
Journal:  J Clin Invest       Date:  2000-11       Impact factor: 14.808

4.  Establishment of stable multiple myeloma cell line with overexpressed PDCD5 and its proapoptosis mechanism.

Authors:  Wenchang Feng; Yunfeng Fu; Yanan Zhang; Ben Lv; Xin Li; Fan Zhang; Rong Gui; Jing Liu
Journal:  Int J Clin Exp Pathol       Date:  2015-09-01

5.  Hyperlipidemia modifies innate immune responses to lipopolysaccharide via the TLR-NF-κB signaling pathway.

Authors:  Shuai Chen; Gengbing Lin; Lang Lei; Xiaoqing You; Chunfang Wu; Wenjing Xu; Min Huang; Lan Luo; Zhijun Wang; Yanfen Li; Xin Zhao; Fuhua Yan
Journal:  Inflammation       Date:  2013-08       Impact factor: 4.092

6.  The Megalocytivirus RBIV Induces Apoptosis and MHC Class I Presentation in Rock Bream (Oplegnathus fasciatus) Red Blood Cells.

Authors:  Myung-Hwa Jung; Verónica Chico; Sergio Ciordia; Maria Carmen Mena; Sung-Ju Jung; Maria Del Mar Ortega-Villaizan
Journal:  Front Immunol       Date:  2019-03-04       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.